Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Diabetologia
|
July 10, 2020
Association between hospital admission for ketoacidosis and subsequent suicide attempt in young adults with type 1 diabetes
Jean-Michel Petit, Karine Goueslard, Jean-Christophe Chauvet-Gelinier, et al.
Atherosclerosis
|
January 17, 2016
Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome
Damien Denimal, Amandine Nguyen, Jean-Paul Pais de Barros, et al.
Diabetes Care
|
February 25, 2026
Effects of Sodium/Glucose Cotransporter-2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer
Clothilde Dumortier, Serge Aho Glele, Alexia Rouland, et al.
Journal of Diabetes Science and Technology
|
February 11, 2021
Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
Bruno Vergès, Elise Pignol, Alexia Rouland, et al.
Diabetes Research and Clinical Practice
|
May 3, 2011
Low HDL-cholesterol: a strong predictor of glycemic response to glitazone treatment in patients with type 2 diabetes
Bruno Vergès, Laura Radu, Sabine Baillot-Rudoni, et al.
Journal of Lipid Research
|
April 5, 2012
Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease
Xavier Pillois, Thomas Gautier, Benjamin Bouillet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2016
Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study
Jean-Michel Petit, Jean-Pierre Cercueil, Romaric Loffroy, et al.
Diabetes & Metabolism
|
April 23, 2024
No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes
Laurence Duvillard, Jean-Paul Pais de Barros, Alexia Rouland, et al.
Diabetes Care
|
February 28, 2014
Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes
Benjamin Bouillet, Thomas Gautier, Denis Blache, et al.
Diabetes & Metabolism
|
March 16, 2021
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer
Bruno Vergès, Roxane Brands, Coralie Fourmont, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Diabetologia
|
July 10, 2020
Association between hospital admission for ketoacidosis and subsequent suicide attempt in young adults with type 1 diabetes
Jean-Michel Petit, Karine Goueslard, Jean-Christophe Chauvet-Gelinier, et al.
Atherosclerosis
|
January 17, 2016
Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome
Damien Denimal, Amandine Nguyen, Jean-Paul Pais de Barros, et al.
Diabetes Care
|
February 25, 2026
Effects of Sodium/Glucose Cotransporter-2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer
Clothilde Dumortier, Serge Aho Glele, Alexia Rouland, et al.
Journal of Diabetes Science and Technology
|
February 11, 2021
Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
Bruno Vergès, Elise Pignol, Alexia Rouland, et al.
Diabetes Research and Clinical Practice
|
May 3, 2011
Low HDL-cholesterol: a strong predictor of glycemic response to glitazone treatment in patients with type 2 diabetes
Bruno Vergès, Laura Radu, Sabine Baillot-Rudoni, et al.
Journal of Lipid Research
|
April 5, 2012
Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease
Xavier Pillois, Thomas Gautier, Benjamin Bouillet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2016
Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study
Jean-Michel Petit, Jean-Pierre Cercueil, Romaric Loffroy, et al.
Diabetes & Metabolism
|
April 23, 2024
No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes
Laurence Duvillard, Jean-Paul Pais de Barros, Alexia Rouland, et al.
Diabetes Care
|
February 28, 2014
Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes
Benjamin Bouillet, Thomas Gautier, Denis Blache, et al.
Diabetes & Metabolism
|
March 16, 2021
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer
Bruno Vergès, Roxane Brands, Coralie Fourmont, et al.
Page
of 8